✦ LIBER ✦

Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin’s lymphoma (NHL)

✍ Scribed by Emma Morris; Stephen Mackinnon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced-intensity conditioning for allog

✍ Karl S. Peggs; Anna Sureda; Wendi Qian; Dolores Caballero; Ann Hunter; Alvaro Ur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Reduced intensity conditioning and allog

✍ Wulf, G G; Hasenkamp, J; Jung, W; Chapuy, B; Truemper, L; Glass, B 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

A pilot study of myeloablative (MA) auto

✍ M.B. Bradley; E. Cooney; D. George; J. Garvin; G. Del Toro; M. Bhatia; E. Roman; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Ibritumomab tiuxetan (Zevalin) in the co

✍ A. Shimoni; T. Zwass; Y. Oksman; I. Hardan; N. Shem-Tov; R. Yerushalmi; A. Avigd 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB